Microbial hydrogen “manufactory” for enhanced gas therapy and self-activated immunotherapy via reduced immune escape.
Hongyu Yan, Miao Fan, Huifang Liu, Tingshan Xiao, Dandan Han, Ruijun Che, Wei Zhang, Xiaohan Zhou, June Wang, Chi Zhang, Xinjian Yang, Jinchao Zhang, Zhenhua Li · Journal of nanobiotechnology · 2022
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
Neutral Summary
In a laboratory model, more interestingly, the researchers found that hydrogen therapy induced by the authors' live PSB did not lead to the up-regulation of PD-L1 after stimulating the immune response, which could avoid the tumor immune escape. These findings from a laboratory model add evidence about molecular hydrogen's biological effects in the model studied.
Hydrogen Intervention
Other or not reported
Main Outcome Examined
As an antioxidant, hydrogen (H) can selectively react with the highly toxic hydroxyl radical (·OH) in tumor cells to break the balance of reactive…
Reported Findings
The abstract reports: Hydrogen-immunotherapy significantly kills tumor cells. We believe that our live microbial hydrogen production system provides a new strategy for cancer hydrogen treatment combining with…
Important Limitations
The abstract alone may not report all methodological limitations; full-text review is required.
Safety Findings
The abstract did not provide detailed safety or adverse-event information.
Additional Notes
H2HUBB TAKEAWAY
In a laboratory model, more interestingly, the researchers found that hydrogen therapy induced by the authors' live PSB did not lead to the up-regulation of PD-L1 after stimulating the immune response, which could avoid the tumor immune escape. These findings from a laboratory model add evidence about molecular hydrogen's biological effects in the model studied.
What the Findings Mean
H2HUBB reviewed how molecular hydrogen was evaluated in this publication and summarizes the source-grounded findings below. More interestingly, the researchers found that hydrogen therapy induced by the authors' live PSB did not lead to the up-regulation of PD-L1 after stimulating the immune response, which could avoid the tumor immune escape.
What the Researchers Studied
The study used a in vitro cell-culture laboratory experiment.
What Effects Did Molecular Hydrogen Have?
As an antioxidant, hydrogen (H₂) can selectively react with the highly toxic hydroxyl radical (·OH) in tumor cells to break the balance of reactive oxygen species (ROS) and cause oxidative stress. However, due to the high diffusibility and storage difficulty of hydrogen, it is impossible to achieve long-term release at the tumor site, which highly limited their therapeutic effect. More interestingly, the researchers found that hydrogen therapy induced by the authors' live PSB did not lead to the up-regulation of PD-L1 after stimulating the immune response, which could avoid the tumor immune escape.
Why These Findings Matter
This publication adds useful evidence about where molecular hydrogen did and did not change the measured outcomes, helping define the larger therapeutic evidence base.
How Strong Is This Evidence?
This is laboratory evidence from a in vitro cell-culture laboratory experiment. It is most informative for the biological mechanisms, cellular responses, or biochemical outcomes directly measured.
Technical Study Details
H2HUBB classifies this publication as laboratory study with laboratory or cellular evidence. The study used a in vitro cell-culture laboratory experiment.
Limitations and Safety
No separate limitations or safety findings were identified in the source text available to H2HUBB.
Original Study and H2HUBB Research Context
H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base.